There have been numerous cases reported of the knee replacement failing prematurely, often within the first few years or even months after surgery. The knee implant came onto the market in 2013. If you experienced a premature failure of your knee replacement during the time frame of 2013 to the present.
The Attune Knee System, manufactured by Johnson & Johnson subsidiary DePuy Orthopaedics, is one of the most popular knee replacement devices on the market. Approved by the Food and Drug Administration (FDA) in 2010, the DePuy Attune Knee System was touted as being able to provide patients with increased stability and a better range of motion. However, some patients claim that the Attune knee replacement implants have not lived up to those expectations. In the years since its approval, the FDA has received numerous complaints from DePuy Attune patients who reported complications with their implant, including loosening of tibial components that necessitated painful and invasive revision or reconstructive surgeries.
The DePuy Attune® Knee Replacement is associated with severe side effects including device failure within the first year or two. Hundreds of adverse event reports have been made to the FDA, many of which include reports of loosening with the device resulting in a premature revision surgery. Some of the symptoms also include:
DePuy Knee Implant Problems
Loosening (Tibial Plate)
Failure to Bond
Persistent Warmth/Heat in the Knee
If you or a loved one has suffered any of the injuries above Please contact Jamie Sheller Esq. for a free consultation at 1 800 883 2299
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.